Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients

European Journal of Clinical Pharmacology

Volumn 59, Issue 12, 2004, Pages 855-861

  Roglans, Núria ^a   Vázquez Carrera, Manuel ^a   Alegret, Marta ^a   Novell, Ferran ^a   Zambón, Daniel ^a   Ros, Emilio ^a   Laguna, Juan C ^a   Sánchez, Rosa M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Biliary lipid secretion; CYP7A1; Fibrate

Indexed keywords

ABC TRANSPORTER; ANTILIPEMIC AGENT; ATP BINDING CASSETTE TRANSPORETR G5; ATP BINDING CASSETTE TRANSPORTER G8; BEZAFIBRATE; BINDING PROTEIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HEPATOCYTE NUCLEAR FACTOR 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PLACEBO; PROTEIN; SCAVENGER RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE ACID SYNTHESIS; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; GALLSTONE FORMATION; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTILIPEMIC AGENTS; BEZAFIBRATE; BILE ACIDS AND SALTS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL, LDL; DOWN-REGULATION; FEMALE; GALLSTONES; GEMFIBROZIL; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROCETOFEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 12144288053     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0704-1     Document Type: Article

References (39)

1. Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, Staels B (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 22:717-726
2. Kesäniemi A, Grundy SM (1984) Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. JAMA 251:2241-2246
3. Einarsson K, Angelin B (1986) Hyperlipoproteinemia, hypolipidemic treatment and gallstone disease. Atheroscler Rev 15:67-97
4. Stahlberg D, Reihnér E, Rudling M, Berglund M, Einarsson K, Angelin B (1995) Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7alpha-hydroxylase. Hepatology 21:1025-1030
5. Post SM, Duez H, Gervois PP, Kuipers F, Princen HMG (2001) Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 21:1840-1845
6. Bertolotti M, Concari M, Loria P, Abate N, Pinetti A, Guicciardi ME, Carulli N (1995) Effects of different phenotypes of hypercholesterolemia and of treatment with fibric acid derivatives on the rates of cholesterol 7alpha hydroxylation in humans. Arterioscler Thromb Vasc Biol 15:1064-1069
7. Princen HMG, Post SM, Twisk J (1997) Regulation of bile acid biosynthesis. Curr Pharm Des 3:59-84
8. Chiang JYL (1998) Regulation of bile acid synthesis. Front Biosci 3:D176-D193
9. Davis RA, Miyake JH, Hui TY, Spann NJ (2002) Regulation of cholesterol-7alpha-hydroxylase: barely missing a SHP. J Lipid Res 43:533-543
10. Russell DW, Setchell KD (1992) Bile acid byosinthesis. Biochemistry 31:4737-4749
11. Wang DPD, Stroup M, Marrapodi M, Crestani M, Galli G, Chiang JYL (1996) Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene (CYP7A9) in HepG2 cells. J Lipid Res 37:1831-1841
12. Tobin KA, Steineger HH, Alberti S, Spydevol O, Auwerx J, Gustafsson JK, Nebb HI (2000) Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor alpha. Mol Endocrinol 14:741-752
13. Chiang JY, Kimmel R, Stroup D (2001) Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 262:257-265
14. Bocos C, Castro M, Quack G, Herrera E (1993) Studies with etofibrate in the rat. II: a comparison of the effects of prolonged and acute administration on plasma lipids, liver enzymes and adipose tissue lipolysys. Biochim Biophys Acta 1168:340-347
15. Combettes-Souverain M, Milliat F, Sérougne C, Féré zou J, Lutton C (1999) SR-BI et metabolisme du cholesterol. Medicine/Sciences 15:1252-1258
16. Sehayek E, Ono JG, Shefer S, Nguyen LB, Wang N, Batta AK, Salen G, Smith JD, Tall AR, Breslow JL (1998) Biliary cholesterol excretion: a novel mechanism that regulates cholesterol absorption. Proc Natl Acad Sci U S A 95:10194-10199
17. Fucks M, Ivandic B, Müller O, Schalla C, Scheibner J, Bartsch P, Stange EF (2001) Biliary cholesterol hypersecretion in gall-stone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Hepatology 33:1451-1459
18. Mardones P, Quiñone V, Amigo L, Moreno M, Miquel JF, Schwarz M, Miettinen HE, Trigatti B, Krieger M, VanPatten S, Cohen DE, Rigotti A (2001) Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 42:170-180
19. Schmitz G, Langmann T, Heimerl S (2001) Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res 42:1513-1520
20. Borst P, Zelcer N, van Helvoort A (2000) ABC transporters in lipid transport. Biochim Biophys Acta 1486:128-144
21. Chinetti G, Gbaguidi FG, Griglio S, Mallat Z, Antonucci M, Poulain P, Chapmam J, Fruchart JC, Tedgui A, Najib-Fruchart J, Staels B (2000) CLA-1/SR-BI expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101:2411-2417
22. Chianale J, Vollrath V, Wielandt AM, Amigo L, Rigotti A, Nervi F, Gonzalez S, Andrade L, Pizarro M, Accatino L (1996) Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J 314:781-786
23. Miranda S, Vollrath V, Wielandt AM, Loyola G, Bronfman M, Chianale J (1997) Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver. J Hepatol 26:1331-1339
24. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC (1998) Linkage between cholesterol 7 alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 101:1283-1291
25. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP (2002) Human cholesterol 7 α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109-117
26. Roglans N, Peris C, Verd JC, Alegret M, Vázquez M, Sánchez RM, Laguna JC (2001) Increase in hepatic expression of SREBP-2 by gemfibrozil administration to rats. Biochem Pharmacol 62:803-809
27. Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolisis of a membrane-bound transcription factor. Cell 89:331-340
28. Horton JD, Shimoura I (1999) Sterol regulatory element-binding proteins activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 10:143-150
29. Roglans N, Bellido A, Rodríguez C, Cabrero A, Novell F, Ros E, Zambón D, Laguna JC (2002) Fibrate treatment does not modify the expression of acyl-CoA oxidase in human liver. Clin Pharmacol Ther 72:692-701
30. Roglans N, Sanguino E, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM (2002) Atorvastatin treatment induced PPAR alpha expression and decreased plasma non-esterified fatty acids and liver triglyceride in fructose fed rats. J Pharmacol Exp Ther 302:232-239
31. Gause WC, Adamovicz J (1995) Use of PCR to quantitate relative differences in gene expression. In: Dieffenbach CW and Dveksler GS (eds) PCR primer. A laboratory manual. Cold Spring Harbor Laboratory Press, New York
32. Cheema SK, Agellon LB (2000) The murine and human cholesterol 7 alpha hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha. J Biol Chem 275:12530-12536
33. Marrapodi M, Chiang JYL (2000) Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7 alpha hydroxylase gene (CYP7A1) transcription. J Lipid Res 41:514-520
34. Patel DD, Knight BL, Soutar AK, Gibbons GF, Wade DP (2000) The effect of peroxisome-proliferator-activated receptor alpha on the activity of the cholesterol 7 alpha hydroxylase gene. Biochem J 351:747-753
35. Stahlberg D, Reihnér E, Ewerth S, Einarsson K, Angelin B (1991) Effects of bezafibrate on hepatic cholesterol metabolism. Eur J Clin Pharmacol 40:S33-S36
36. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH (2002) Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A 99:16237-16242
37. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH (2002) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110:671-680
38. Einarsson K, Angelin B (1986) Hyperlipoproteinemia, hypolipidemic treatment, and gallstone disease. Atheroscler Rev 15:67-97
39. Sato R, Inoue J, Kawabe Y, Kodama T, Takano T, Maeda M (1996) Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J Biol Chem 271:26461-26464